Insulet
Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System.
Business Model:
Revenue: $0
Employees: 501-1,000
Rankings
Industries / Tags:
Detailed Insulet Information
Geographic Data
Address:
City: Bedford
State: Massachusetts
Zip:
Country: United States
Financial Info
Stage:
post ipo debt
Raised Last:
$60M
Raised Total:$130M
Social
Metrics
165,019Website Global Rank
464,607Website Monthly Traffic
Twitter Followers
Description
Insulet Corporation, a medical device company, engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes primarily in the United States. The company offers OmniPod Insulin Management System (OmniPod System), an insulin infusion system that provides a pain-free automated cannula insertion. The OmniPod System consists of OmniPod disposable insulin infusion device and handheld wireless personal diabetes manager; and provides people with a diabetes management solution that offers lifestyle and other benefits. The company sells the OmniPod System directly to patients through referrals from healthcare professionals and through patient leads. Insulet Corporation was founded in 2000 and is headquartered in Bedford, Massachusetts.
Contact Phone:
Contact Email:
Insulet went public on 5/15/2007 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/15/2007
Ticker Symbol:
PODD
IPO Price:
$15/share
Amount Raised:
$115M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2009 | Post-IPO Debt | 1 | $60M |
Deerfield Deerfield Deerfield Deerfield |
8/2000 | Series A | 1 | $1M |
Prism Venture Management |
8/2001 | Series B | 3 | $11M |
Schroder Ventures Versant Ventures Prism Venture Management Schroder Ventures Versant Ventures |
3/2004 | Series D | 9 | $35.5M |
Oakwood Medical Investors TIAA Prism Venture Management Versant Ventures Alta Partners Pequot Capital SV Health Investors MedVenture Associates Piper Jaffray Alta Partners Oakwood Medical Investors TIAA Prism Venture Management Versant Ventures Alta Partners Pequot Capital SV Health Investors MedVenture Associates Piper Jaffray Alta Partners |
10/2002 | Series C | 4 | $22M |
Oakwood Medical Investors Prism Venture Management SV Health Investors Versant Ventures Oakwood Medical Investors Prism Venture Management SV Health Investors Versant Ventures |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 6/2011 | Neighborhood Diabetes |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
